has been granted 'Green' label certification for debt issued to develop its Lake Way Project, confirming the positive environmental contribution of fertiliser production at the project in Western Australia.
The 'Green' loan label is set out by the Loan Market Association (“LMA”) and Asia Pacific Loan Market Association (“APLMA”) green loan principles.
The LMA label is a positive indication to the dual-listed mineral exploration group’s debt partners, as well as all other stakeholders including the local community, off takers and suppliers.
The designation also covers associated governance procedures relating to correct management of proceeds and reporting, this morning’s statement detailed.
"We are delighted to have received the 'Green' label designation for the Lake Way Project, confirming the positive environmental contribution our project will make towards reducing emissions from the global fertiliser industry,” said Tony Swiericzuk, CEO of Salt Lake Potash.
Shares in Salt Lake Potash closed at 33.5 on Friday afternoon.
As part of the review, Wood Canada Limited conducted a technical assessment of greenhouse gas emissions of SOP production at Lake Way, relative to Mannheim SOP production in other locations.
The assessment concluded that a Mannheim process plant of comparable capacity would have 60% higher CO2 emissions than the Lake Way Project, the group said.
Meanwhile, the company also cited how investor interest in green investment has grown rapidly over the past decade, with estimates showing the global volume of green debt has grown from less than A$5 billion in 2010 to more than A$150 billion in 2018.
Salt Lake Potash’s long-term plan at Lake Way is to develop an integrated Sulphate of Potash operation, producing from several of its nine salt lakes.
Follow News & Updates from Salt Lake Potash here:
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
Majid Shafiq, CEO of i3 Energy (AIM:I3E), and CFO, Graham Heath, discuss today’s follow-on deal to sell the Gain assets to Harvard Resources which will occur following the completion of the group’s previously announced C$80 million reverse takeover .
i3 Energy plc, an independent oil and gas company with assets and operations in the UK, Final Results for the year ended 31 December 2019 show significant operational progress for the pre-revenue company with net loss of £10.8m. To fund the Gain acquisition announced post period end in 2020, i3 is proposing to raise £30 million at a price of 5 pence per share, an 18% discount to the closing mid-price at which i3's shares suspended on 23 June 2020.
Oilex, the Operator of the PSC and on behalf of the JDPA joint venture, has reached amicable settlement with JPDA in East Timor with a settlement of US$0.8m payable in 2021 and 2022 financial years. The settlement amount is fully provided for in the FY19 accounts.
Avacta Group has entered into a collaboration with the Liverpool School of Tropical Medicine to clinically validate the rapid, saliva-based coronavirus antigen test that Avacta is developing in conjunction with Cytiva.
Shield Therapeutics said a reanalysis of the AEGIS-H2H study for its iron deficiency lead product Feraccru®/Accrufer® has confirmed the product as a credible alternative to IV therapy for patients with iron deficiency anaemia.